Scott, a real HAE patient, helps prevent his attacks with CINRYZE

Cinryze offers
the power of
proven prevention

CINRYZE (C1 esterase inhibitor [human]) is the first FDA-approved C1 esterase inhibitor (C1-INH) to help prevent HAE attacks in patients 6 years of age and older. CINRYZE has been proven to reduce attack frequency, severity, and the number of days of swelling.

Give your patients the power of prevention along their HAE journey.

The first C1-INH therapy indicated to help prevent HAE attacks in adults, adolescents and pediatric patients (6 years of age and older)

CINRYZE (C1 esterase inhibitor [human]) was the first FDA-approved C1 esterase inhibitor (C1-INH) to help prevent HAE attacks in patients 6 years of age and older. CINRYZE has been proven to reduce attack frequency, severity, and the number of days of swelling.

Give your patients the power of prevention along their HAE journey.

PROVEN PREVENTION

How CINRYZE works

Learn how CINRYZE replaces missing or dysfunctional C1 esterase inhibitor.1,2

Douglas T. Johnston,
D.O., FAAAAI, FACAAI

Put your patients on the path to Proven Prevention

Prescribe CINRYZE for your patients and give them access to preventative therapy for their journey with HAE.1

Scott, a real HAE patient, helps prevent his attacks with CINRYZE.

Learn about pediatric use

Find out more about the expanded indication of CINRYZE to include patients aged 6 to 11.

Learn more

Explore resources for patients

Patients can receive product support services from OnePath® Patient Support Managers and other OnePath team members as needed.

See product support services


See CINRYZE's efficacy

Safety and efficacy were evaluated in adults, adolescents, and children as young as 71.

View study results

Request a sales representative

If you'd like to learn more about CINRYZE for your HAE patients, please get in touch.

Complete a request form

References

  1. CINRYZE® (C1 esterase inhibitor [human]) Prescribing Information. Shire.
  2. Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008;359(10):1027-1036. doi:10.1056/NEJMcp0803977.

Definition: